Rising prevalence of nosocomial infection is the major driving factor for hospital acquired disease testing market

Published Date: September 5, 2020 |

Rising prevalence of nosocomial infection is the major driving factor for hospital acquired disease testing market

The global hospital acquired disease testing market is expected to grow at the CAGR of around 14% during 2020-2027. The global hospital acquired disease testing market is segmented on the basis of infection type and geography. The report on global hospital acquired disease testing market forecast 2020-2027 (by infection type and geography) provides a detailed overview and predictive analysis of the market.

Full report available on Global Hospital Acquired Disease Testing market: Global Industry Size, Growth, Share and Forecast to 2025 report at https://www.researchcorridor.com/hospital-acquired-disease-testing-market/

Market Insights

Hospital infection also known as nosocomial infection, is the infection acquired by patient during the stay in hospital, which was previously not observed. The infection is acquired due to immune compromised patient, prolonged stay in hospital, hospital or staff negligence in carrying out procedure or maintaining the hygiene. According to a survey 9.2 patients from 100 in the U.S. suffer from hospital infection. Nowadays, nosocomial infection is commonly observed which is adding up to the burden of mortality and morbidity of hospital and increase in cost pressure. Thus stringent regulation and guidelines are coming up with respect to hospital hygiene and standard protocol to be followed, which acts main driver for the nosocomial infection market.

Hospital acquired infection is occurs when the patient is admitted in the hospital and was not present or incubating at the time of admission. It is also called nosocomial infection which can be caused from fungi, bacteria, virus and parasites. Most of the patients, especially immune compromised, geriatric, pediatric population, catheter using patients, those with prolonged stay in hospitals are more susceptible to infection in hospital. Thus regulatory bodies and governments are coming with stringent guidelines and standard protocols to be followed to maintain sterilization and disinfection level in hospitals to avoid further mortality and morbidity, which act as major driving factor for hospital acquired infection market.

Market Segment Insights:

On the basis of infection types, the global hospital acquired disease testing market is majorly segmented into pneumonia, surgical site infection, urinary tract infection, bloodstream infection, MRSA and others. Pneumonia and urinary tract infection are the most common hospital acquired infections and the largest market segments.

Global Hospital Acquired Disease Testing Market Segmentation:

By Infection Type, 2018–2027 ($ Million)

  • Pneumonia
  • Urinary Tract Infection
  • Blood Stream Infection
  • Surgical Site Infection
  • MRSA
  • Others

By Geography, 2018-2027 ($ Million)

  • North America (U.S. & Canada)
  • Europe (U.K., Germany & Rest of Europe)
  • Asia Pacific (China, Japan, and Rest of APAC)
  • Latin America (Brazil, Mexico and Rest of LATAM)
  • Middle East and Africa (UAE, Saudi Arabia, South Africa)

Regional Insights:

North America occupies the largest market share for global hospital acquired disease testing market. The factors responsible for the growth of the market are rising prevalence of hospital acquired infection, increase in hospital admission, multidrug resistant microbe. Asia Pacific is the most attractive market and anticipate extensive growth during the forecast period. The key factors for the growth of Asia Pacific region are the stringent guidelines by WHO and regulation by government in emerging countries with respect to hospital hygiene and sterilization.

Request a free report sample @ https://www.researchcorridor.com/request-sample/?id=1920

Market Competition Assessment:

Key players in the hospital acquired disease testing market are: Becton Dickinson, Diatherix Corp, Roche, Nordion, Cantel Medical Corporation, Cephid, Qiagen, BioMeriux and others.

  • Becton Dickinson
  • BioMerieux
  • Cepheid Inc
  • Cantel Medical Corp.
  • Qiagen
  • Diatherix Laboratories
  • Roche Holding AG
  • Nordion Inc
  • Others
Fill the given form to request sample for Rising prevalence of nosocomial infection is the major driving factor for hospital acquired disease testing market Market Report [contact-form-7 id="143911" title="Request Sample"]
Fill the given form to inquiry before buying for Rising prevalence of nosocomial infection is the major driving factor for hospital acquired disease testing market Market Report [contact-form-7 id="143909" title="Inquiry Buying"]